4//SEC Filing
EVANS HANDEL 4
Accession 0000850693-05-000079
CIK 0000850693other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 8:15 PM ET
Size
12.9 KB
Accession
0000850693-05-000079
Insider Transaction Report
Form 4
ALLERGAN INC(AGN)
EVANS HANDEL
Director
Transactions
- Award
Phantom Stock Units
2005-04-25$72.98/sh+13.7$1,000→ 27,742.19 total→ Common Stock (0 underlying) - Award
Phantom Stock Units
2005-04-26$73.01/sh+27.39$2,000→ 27,783.28 total→ Common Stock (0 underlying) - Award
Nonemployee Director Stock Option (Right to Buy)
2005-04-26+2,500→ 2,500 totalExercise: $72.98From: 2006-04-26Exp: 2015-04-26→ Common Stock (2,500 underlying)
Footnotes (5)
- [F1]The per share exercise price is the closing price of Allergan common stock as of April 25, 2005, rounded upwards to three decimals.
- [F2]Option is fully vested and exercisable on the one year (1) year anniversary of its grant.
- [F3]Converts to common stock on a 1-for-1 basis.
- [F4]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
- [F5]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.
Documents
Issuer
ALLERGAN INC
CIK 0000850693
Entity typeother
Related Parties
1- filerCIK 0001016356
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 8:15 PM ET
- Size
- 12.9 KB